BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6294199)

  • 1. [A case of glucagonoma].
    Numakawa T; Ikeuchi T; Sugimasa T; Inoue S; Takamura Y; Suda T
    Nihon Naika Gakkai Zasshi; 1982 Jul; 71(7):977-84. PubMed ID: 6294199
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glucagonoma syndrome with normal blood glucagon ].
    Quencez E; Zultak M; Blanc D; Gillet M; Laurent R
    Ann Dermatol Venereol; 1987; 114(9):1103-8. PubMed ID: 2829690
    [No Abstract]   [Full Text] [Related]  

  • 3. [Glucagonoma and somatostatinoma].
    Yoshida H; Shimizu N
    Nihon Rinsho; 1982 Feb; 40(2):441-5. PubMed ID: 6283209
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case report of malignant glucagonoma with a profile of immunoreactive glucagon before and after the operation].
    Ohtsuka K; Nimura Y; Takaesu H; Yokoi S; Shionoya S; Yasui K
    Nihon Shokakibyo Gakkai Zasshi; 1986 Oct; 83(10):2223-6. PubMed ID: 3029475
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glucagonoma syndrome with a normal blood glucose curve].
    González de Zárate Apiñariz P; Alonso Alonso J; Vázquez García JA; Hernández Calvo J; Burgos Bretones J; Aguirre Errasti C; Díaz Pérez JL
    Med Clin (Barc); 1983 Oct; 81(9):396-8. PubMed ID: 6316044
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pancreatic glucagonoma. Apropos of a case].
    Mathis P; Diebold MD; Servel R
    Chirurgie; 1987; 113(3):258-61. PubMed ID: 2820663
    [No Abstract]   [Full Text] [Related]  

  • 7. A Chinese woman with glucagonoma syndrome.
    Leung CB; Yeung VT; Chung SC; Chan JC; Cockram CS
    Chin Med J (Engl); 1992 Jun; 105(6):514-7. PubMed ID: 1333392
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucagonoma syndrome.
    Hashizume T; Kiryu H; Noda K; Kano T; Nakano R
    J Am Acad Dermatol; 1988 Aug; 19(2 Pt 2):377-83. PubMed ID: 2842381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent pheochromocytoma associated with glucagonoma. A case report.
    Yao H; Fukiyama K; Kawano Y; Mizumoto K; Toyoshima S; Omae T
    Endocrinol Jpn; 1983 Apr; 30(2):163-6. PubMed ID: 6139277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
    Torre L; Vazquez JA; Blázquez E
    Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glucagonoma with diabetic ketoacidosis; case report].
    Lefebvre J; Lelièvre G; Dalle-Furnari MA; Proye C; Mazzuca M; Garraud JC; Luyckx A; Linquette M
    Diabete Metab; 1982 Sep; 8(3):191-5. PubMed ID: 6292011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagonoma: anaesthetic management.
    Gin VC; Zacharias M
    Anaesth Intensive Care; 2009 Mar; 37(2):329-30. PubMed ID: 19400510
    [No Abstract]   [Full Text] [Related]  

  • 13. Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
    Moattari AR; Cho K; Vinik AI
    Surgery; 1990 Sep; 108(3):581-7. PubMed ID: 2168587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of somatostatin and somatostatin analogs in a patient with a glucagonoma.
    Kahn CR; Bhathena SJ; Recant L; Rivier J
    J Clin Endocrinol Metab; 1981 Sep; 53(3):543-9. PubMed ID: 6114963
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glucagon producing tumors of the pancreas. A case report and literature review].
    Linnestad P; Myrvang B; Ritland S; Bergan A; Valnes K; Holst JJ
    Tidsskr Nor Laegeforen; 1983 Aug; 103(22):1520-2. PubMed ID: 6314588
    [No Abstract]   [Full Text] [Related]  

  • 16. Necrolytic migratory erythema and glucagon cell tumour of the pancreas: the glucagonoma syndrome. Report of two cases.
    Pedersen NB; Jonsson L; Holst JJ
    Acta Derm Venereol; 1976; 56(5):391-5. PubMed ID: 78626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant pancreatic glucagonoma treated by total radical pancreatectomy. 1st Spanish case report and review of the world literature].
    Martínez Díez M; Castiella Muruzábal T; Aguilella Diago V; Ingelmo Setien A; García Gil A; Garín Chesa P; González González M
    Rev Esp Enferm Apar Dig; 1983 May; 63(5):401-20. PubMed ID: 6308726
    [No Abstract]   [Full Text] [Related]  

  • 18. The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500.
    Hendriks T; Jansen JB; van Tongeren JH
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):226-32. PubMed ID: 6141691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreduction surgery for metastatic glucagonoma. A clinicopathologic study with special reference to the utility of immunocytochemistry and ultrastructure in diagnosis.
    Rader DL; Martin JK; Scheithauer BW
    Minn Med; 1984 Sep; 67(9):483-5, 516. PubMed ID: 6092886
    [No Abstract]   [Full Text] [Related]  

  • 20. [Glucagonoma without the glucagonoma syndrome].
    Morosini M; Sommo M; Marconi R
    Minerva Chir; 1985 May; 40(10):707-9. PubMed ID: 2993957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.